Poppy Playtime Chapter 5 starts off with an old commercial for one of the new toys you'll encounter, just like previous ...

Review - If you want a clear example of ambition outstripping the execution, then Clue: Murder By Death is your case.

Psychedelic drug developer Compass Pathways is preparing to talk to the FDA about filing its psilocybin therapy COMP360 for approval in treatment-resistant depression (TRD), after reporting positive ...

Shares in psychedelic drug developer Compass Pathways are sliding today after it announced that it will slash its headcount by 30% and focus all its efforts on its treatment-resistant depression (TRD) ...

Learn how to find the current needed to deflect a compass needle in this step-by-step physics tutorial! Explore the ...

PayPal Holdings Inc. (NASDAQ:PYPL) is one of the best large cap stocks to buy under $50. On February 3, Compass Point upgraded PayPal to Neutral from Sell with a price target of $51, which was brought ...

Investing.com - Compass Point initiated coverage on BitGo Holdings (NYSE:BTGO) with a Buy rating and set a price target of $17.00, according to a research note published Monday. This target represents ...

Rocket Pro adds Pro Purchase Power, offering 40 bps more with Compass buyer agents, and launches Jupiter loan origination ...

Investing.com - Compass Point upgraded Upstart Holdings Inc (NASDAQ:UPST) to Neutral from Sell on Tuesday and raised its price target to $30 from $20, closely aligning with the stock’s current trading ...

Compass Point is adopting a bullish stance on Nebius Group . The firm initiated the artificial intelligence infrastructure ...

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Ed Engel, Compass Point senior research analyst, joins 'The Exchange' to discuss a potential bottom in crypto prices, what another retest of the lows could mean and much more. Got a confidential news ...